Medication info

Taeguk Rosartan Tablet (Losartan Potassium)

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Taeguk Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets per bottle, 200 tablets per bottle
Approval status
Expired

MFDS item code 200501050 · Notified 2005.08.10

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is inadequate, the same dose may be taken orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations Older adults No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with decreased effective intravascular blood volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have decreased effective intravascular blood volume (e.g., patients being treated with diuretics) (see the Precautions for Use section). Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric and adolescent patients 6 years of age and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, and may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, and may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Taeguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension and helps prevent and slow the progression of kidney disease, particularly in patients with type 2 diabetes who have hypertension. Therefore, it is effective not only for hypertension but also for improving related kidney complications. This drug is used to improve kidney health in patients with hypertension and diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is inadequate, the same dose may be taken orally in 2 divided doses daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations Older adults No adjustment of the initial dose is necessary in older adults 75 years of age or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with decreased effective intravascular blood volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have decreased effective intravascular blood volume (e.g., patients being treated with diuretics) (see the Precautions for Use section). Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric and adolescent patients 6 years of age and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, and may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, and may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not use it. Patients with severely impaired liver or kidney function, hereditary angioedema, and certain lactose intolerance should not take this medication. Elderly patients, patients with hyperkalemia, and those with liver or heart problems need to be cautious while taking this medication, as blood pressure may drop too low or kidney function may worsen, necessitating regular check-ups. This medication is generally safe but may cause side effects such as dizziness, muscle cramps, lower back pain, cough, and indigestion, so immediate consultation with healthcare professionals is required if any unusual symptoms occur. There may be interactions when taking this medication with others, especially with potassium-sparing diuretics or potassium supplements, which can cause dangerously high potassium levels in the blood, so caution is advised. While taking this medication, blood pressure, kidney function, and electrolyte levels should be regularly monitored, and if sudden symptoms of low blood pressure appear, healthcare professionals should be notified immediately. It is advisable for pregnant or breastfeeding women not to use this medication, and if it must be taken, it should be done carefully after consulting an expert. Children or those under 6 years of age should not be used as safety and efficacy have not been confirmed.

Side effects

  • Craniosynostosis
  • Anuria
  • Hypotension
  • Renal failure
  • Muscle cramps
  • Lumbago
  • Leg pain
  • Dizziness
  • Congestion
  • Upper respiratory infection
Show 125 more
  • Sinusitis
  • Nausea
  • Diarrhea
  • Dyspepsia
  • Cough
  • Sinus disorder
  • Pharyngitis
  • Myalgia
  • Insomnia
  • Headache
  • Weakness
  • Fatigue
  • Edema
  • Bloating
  • Abdominal pain
  • Chest pain
  • Lip swelling
  • Eyelid swelling
  • Facial rash
  • Palm desquamation
  • Hemolysis
  • Facial edema
  • Fever
  • Orthostatic effect
  • Syncope
  • Angina pectoris
  • 2nd degree AV block
  • Cerebrovascular accident
  • Myocardial infarction
  • Atrial fibrillation
  • Arrhythmia
  • Palpitations
  • Bradycardia
  • Tachycardia
  • Ventricular tachycardia
  • Ventricular fibrillation
  • Anorexia
  • Constipation
  • Toothache
  • Xerostomia
  • Flatulence
  • Gastritis
  • Vomiting
  • Anemia
  • Gout
  • Upper limb pain
  • Hip joint pain
  • Joint swelling
  • Knee pain
  • Myasthenia
  • Shoulder pain
  • Muscle rigidity
  • Arthralgia
  • Arthritis
  • Fibromyalgia
  • Anxiety
  • Anxiety disorder
  • Ataxia
  • Confusion
  • Depression
  • Nightmares
  • Hypoesthesia
  • Decreased libido
  • Memory impairment
  • Migraine
  • Nervous hyperexcitability
  • Paresthesia
  • Peripheral neuropathy
  • Panic disorder
  • Sleep disorder
  • Hypersomnia
  • Tremor
  • Dyspnea
  • Bronchitis
  • Pharyngeal discomfort
  • Epistaxis
  • Rhinitis
  • Respiratory congestion
  • Chest discomfort
  • Hair loss
  • Dermatitis
  • Dry skin
  • Purpura
  • Erythema
  • Flushing
  • Phototoxic reaction
  • Itching
  • Rash
  • Sweating
  • Hives
  • Blurred vision
  • Eye burning
  • Eye pain
  • Conjunctivitis
  • Dysgeusia
  • Tinnitus
  • Visual impairment
  • Erectile dysfunction
  • Nocturnal enuresis
  • Frequent urination
  • Urethral infection
  • Angioedema
  • Vasculitis
  • Anaphylaxis-like syndrome
  • Liver dysfunction
  • Hepatitis
  • Lethargy
  • Thrombocytopenia
  • Myalgia
  • Weakness
  • Elevated creatine kinase
  • Rhabdomyolysis
  • Dysgeusia
  • Dry cough
  • Erythema
  • Hyperkalemia
  • Hyponatremia
  • Elevated ALT
  • Syncope
  • Loss of consciousness
  • Acute hepatitis
  • Fulminant hepatitis
  • Ventricular premature beats
  • Atrial fibrillation
  • Hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets per bottle, 200 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.